Back to IMVT

SILVERARC CAPITAL MANAGEMENT, LLC → IMVT

SILVERARC CAPITAL MANAGEMENT, LLC IMVT Position History

Immunovant, Inc. • Healthcare

Quarters held
3
Latest value
$21.1M
Q3 2026
Peak value
$23.9M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$10.3M
Q2 2026$23.9M
Q3 2026$21.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$21.1M624.1K——
Q2 2026$23.9M619.1K——
Q1 2026$10.3M414.2K——

Other funds holding IMVT

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
ASND

ASCENDIS PHARMA A/S

$55M
DNTH

DIANTHUS THERAPEUTICS INC

$54.9M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M